NASDAQ: JRVRJames River Group Holdings Ltd Stock
$4.29-0.01 (-0.23%)
Updated Apr 17, 2025
JRVR Price
$4.29
Fair Value Price
N/A
Market Cap
$195.81M
52 Week Low
$3.00
52 Week High
$9.56
P/E
-1.4x
P/B
0.42x
P/S
0.27x
PEG
N/A
Dividend Yield
2.8%
Revenue
$707.63M
Earnings
-$81.12M
Gross Margin
21.7%
Operating Margin
-9.06%
Profit Margin
-16.7%
Debt to Equity
9.58
Operating Cash Flow
-$247M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
JRVR Overview
James River Group Holdings, Ltd., through its subsidiaries, provides specialty insurance and reinsurance services in the United States. It operates through Excess and Surplus Lines, Specialty Admitted Insurance, and Casualty Reinsurance segments. The Excess and Surplus Lines segment underwrites liability and property insurance on an excess and surplus commercial lines basis in all states and the District of Columbia. This segment distributes its insurance policies primarily through wholesale insurance brokers. The Specialty Admitted Insurance segment provides workers' compensation coverage for building trades, healthcare employees, goods and services, light manufacturing, specialty transportation, and agriculture, as well as fronting and program business. The Casualty Reinsurance segment offers proportional and working layer casualty reinsurance to third parties and other insurance companies. James River Group Holdings, Ltd. was founded in 2002 and is headquartered in Pembroke, Bermuda.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine JRVR's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Insurance
Industry Rating
C
JRVR
Ranked#20 of 20
Ranked#20 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $22.51 | B | |
| $230.50 | B | |
| $94.59 | B |
Be the first to know about important JRVR news, forecast changes, insider trades & much more!
JRVR News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how JRVR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
JRVR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
JRVR is good value based on its book value relative to its share price (0.42x), compared to the US Insurance - Specialty industry average (1.71x)
P/B vs Industry Valuation
JRVR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more JRVR due diligence checks available for Premium users.
Valuation
JRVR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.4x
Industry
25.75x
Market
27.98x
JRVR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
1.71x
JRVR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
JRVR's financial health
Profit margin
Revenue
$126.7M
Net Income
-$64.8M
Profit Margin
-74.2%
JRVR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.0B
Liabilities
$4.4B
Debt to equity
9.58
JRVR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
JRVR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$7.5M
Investing
-$121.2M
Financing
$9.8M
JRVR vs Specialty Insurance Stocks
James River Group Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.